FDA Inspection
Excella GmbH & Co. KGExcella GmbH & Co. KG – FDA Inspection, May 17, 2013
Record Details
This FDA Inspection record concerns Excella GmbH & Co. KG, with an inspection on May 17, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Excella GmbH & Co. KG
- Inspection Date
- May 17, 2013
- Product Type
- Drugs
View Company Profile
ID · d6a54ce5-0fe9-4001-ba32-977c14744432
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 831974
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Excella GmbH & Co. KG
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | Not classified | Office of Inspections and Investigations | |
| March 17, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 29, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Excella GmbH & Co. KG
- FDA Inspection 1205496 - 2022-10-19
- FDA Inspection 1098271 - 2019-07-12
- FDA Inspection 1064238 - 2018-08-10
- FDA Inspection 1012240 - 2017-03-17
- FDA Inspection 933855 - 2015-05-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.